In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.

Inclusion Criteria:

• Adults (18+) with overweight or obesity (BMI >25 kg/m2)
• Not currently taking an incretin-based medication at baseline
• Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
• Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
• Fluent in English

Exclusion Criteria:

• Adults (18+) without overweight or obesity
• <18 years of age at time of testing
• Adults not taking a GLP-1 Medication
• Adults taking a compound GLP-1
• Adults on GLP-1 medication for longer than 2 weeks at baseline
• Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
• Not fluent in English

Participants will be identified from a list of medical patients prescribed GLP-1 medication by their physicians (located in offices near State College or Hershey, PA) and who volunteered to be contacted regarding studies they are eligible for.